Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Eur J Immunol 2013 Jul 10;43(7):1940-52. Epub 2013 Jun 10.

Jenner Institute, Old Road Campus Research Building, Oxford, UK.

Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin (HA) that are limited in their ability to protect against different strains of influenza. Cytotoxic T lymphocytes recognizing the conserved internal nucleoprotein (NP) and matrix protein (M1) are capable of mediating a cross-subtype immune response against influenza. Modified vaccinia Ankara (MVA) virus encoding NP and M1 (MVA-NP+M1) is designed to boost preexisting T-cell responses in adults in order to elicit a cross-protective immune response. We examined the coadministration of HA protein formulations and candidate MVA-NP+M1 influenza vaccines in murine, avian, and swine models. Ab responses postimmunization were measured by ELISA and pseudotype neutralization assays. Here, we demonstrate that MVA-NP+M1 can act as an adjuvant enhancing Ab responses to HA while simultaneously inducing potent T-cell responses to conserved internal Ags. We show that this regimen leads to the induction of cytophilic Ab isotypes that are capable of inhibiting hemagglutination and in the context of H5 exhibit cross-clade neutralization. The simultaneous induction of T cells and Ab responses has the potential to improve seasonal vaccine performance and could be employed in pandemic situations.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242922DOI Listing
July 2013

Publication Analysis

Top Keywords

influenza vaccines
12
t-cell responses
8
immune response
8
seasonal influenza
8
conserved internal
8
influenza
7
responses
6
responses adults
4
adults order
4
inhibiting hemagglutination
4
neutralization simultaneous
4
examined coadministration
4
capable inhibiting
4
order elicit
4
isotypes capable
4
response influenza
4
cross-protective immune
4
elicit cross-protective
4
preexisting t-cell
4
response examined
4

Similar Publications